Literature DB >> 21748106

Hypoparathyroidism in adult patients with Beta-thalassemia major.

Gihan Ali A M Sleem1, Ibrahim S Al-Zakwani, Muhanna Almuslahi.   

Abstract

OBJECTIVE: To evaluate the prevalence of hypoparathyroidism in adult transfusion-dependent patients with beta-thalassemia major in a teaching referral hospital in Oman.
METHODS: All adult (>13 years) patients with beta-thalassemia major seen at Royal Hospital in Oman between 2004 and 2006 were studied. Demographic, pharmaceutical, clinical and biochemical data were collected for all the subjects. Analyses were performed using both descriptive and univariate statistics.
RESULTS: A total of 31 patients were included into the study with an overall mean age of 19±3 years ranging from 14 to 30 years. Just over half of the subjects were males (n=16; 52%). All the patients were on hypertransfusion and combined chelation therapy with desferrioxamine 40-60 mg/kg 5 days per week and deferiprone 75 mg/kg/day. Three of the patients had low levels of parathyroid hormone (<1.6 pmol/l). A further three patients had normal levels of parathyroid hormone (1.6 - 9.3 pmol/l) in the presence of low serum calcium levels (<2.1 mmol/l). These patients (with normal hypoparathyroid hormone levels, but lower calcium levels) were also defined to have hypoparathyroidism bringing the total prevalence of hypoparathyroidism in this cohort of adult patients with Beta-thalassemia major to 19% (6 out of 31). The patients with hypoparathyroidism had statistically significantly lower levels of parathyroid hormone (2.7 versus 5.3 pmol/l; p=0.031) and serum calcium (1.7 versus 2.3 pmol/l; p=0.004) compared to those without hypoparathyroidism.
CONCLUSION: The prevalence of hypoparathyroidism in adult beta-thalassemia major patients at this referral center was significantly higher (19%) than those reported elsewhere (2.5 and 10.7%).

Entities:  

Keywords:  Beta-thalassemia; Hypoparathyroidism; Oman; Thalassemia major

Year:  2007        PMID: 21748106      PMCID: PMC3074875     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  13 in total

1.  Longitudinal monitoring of bone mineral density in thalassemic patients. Genetic structure and osteoporosis.

Authors:  A Filosa; S Di Maio; S Vocca; A Saviano; G Esposito; L Pagano
Journal:  Acta Paediatr       Date:  1997-04       Impact factor: 2.299

2.  Hypoparathyroidism associate with thalassemia.

Authors:  O F Gabriele
Journal:  South Med J       Date:  1971-01       Impact factor: 0.954

3.  Growth and sexual maturation in thalassemia major.

Authors:  C Borgna-Pignatti; P De Stefano; L Zonta; C Vullo; V De Sanctis; C Melevendi; A Naselli; G Masera; S Terzoli; V Gabutti
Journal:  J Pediatr       Date:  1985-01       Impact factor: 4.406

4.  Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.

Authors:  Nicholas G Angelopoulos; Anastasia Goula; Grigorios Rombopoulos; Victoria Kaltzidou; Eugenia Katounda; Dimitrios Kaltsas; George Tolis
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Endocrine complications in patients with beta-thalassemia major.

Authors:  Yesim Aydinok; Sukran Darcan; Aziz Polat; Kaan Kavakli; Güngör Nigli; Mahmut Coker; Mehmet Kantar; Nazan Cetingul
Journal:  J Trop Pediatr       Date:  2002-02       Impact factor: 1.165

6.  Survival and causes of death in thalassaemia major.

Authors:  M G Zurlo; P De Stefano; C Borgna-Pignatti; A Di Palma; A Piga; C Melevendi; F Di Gregorio; M G Burattini; S Terzoli
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

7.  Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.

Authors:  Jimmy P S Chern; Kai-Hsin Lin
Journal:  J Pediatr Hematol Oncol       Date:  2002-05       Impact factor: 1.289

8.  Multiple hormone deficiencies in children with hemochromatosis.

Authors:  K E Oerter; G A Kamp; P J Munson; A W Nienhuis; F G Cassorla; P K Manasco
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

Review 9.  Thalassemia major 1995: older patients, new therapies.

Authors:  D Rund; E Rachmilewitz
Journal:  Blood Rev       Date:  1995-03       Impact factor: 8.250

10.  Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.

Authors: 
Journal:  Clin Endocrinol (Oxf)       Date:  1995-06       Impact factor: 3.478

View more
  4 in total

1.  Non-invasive haemoglobin estimation in patients with thalassaemia major.

Authors:  Murtadha K Al Khabori; Arwa Z Al-Riyami; Khalil Al-Farsi; Mohammed Al-Huneini; Abdulhakeem Al-Hashim; Nasser Al-Kemyani; Issa Al-Qarshoubi; Hammad Khan; Khalfan Al-Amrani; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

2.  Biochemical Markers of Bone Turnover in Patients with β-Thalassemia Major: A Single Center Study from Southern Pakistan.

Authors:  Sadia Sultan; Syed Mohammed Irfan; Syed Ijlal Ahmed
Journal:  Adv Hematol       Date:  2016-02-23

3.  Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran.

Authors:  Ali Bazi; Hadi Harati; Ali Khosravi-Bonjar; Elham Rakhshani; Mojtaba Delaramnasab
Journal:  Int J Endocrinol Metab       Date:  2018-02-10

4.  Under-recognized Hypoparathyroidism in Thalassemia

Authors:  Hataitip Tangngam; Pat Mahachoklertwattana; Preamrudee Poomthavorn; Ampaiwan Chuansumrit; Nongnuch Sirachainan; La-or Chailurkit; Patcharin Khlairit
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.